EXTON, Pa. and COURBEVOIE, France, April 1
(Bernama-GLOBE NEWSWIRE) -- Morphotek®, Inc., a
subsidiary of Eisai Inc., and AREVA Med, the AREVA Group medical subsidiary
developing innovative therapies to fight cancer, announced today that they have
entered into a collaborative project to assess the potential of a novel alpha
radio-immunotherapy treatment in the fight against cancer.
No comments:
Post a Comment